The Global Vaccine and Immunization Research Forum (GVIRF) is a platform for scientific exchange and engagement among vaccine and immunization research communities, intended to enhance vaccine discovery, development, and deployment. The GVIRF is facilitated by NIAID, the Bill & Melinda Gates Foundation, and the World Health Organization.
In 2010, global health leaders launched the Decade of Vaccines collaboration and created the 2010 Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths through more equitable access to vaccines for people in all communities. GVIRF brings together the entire vaccine and immunization research community biennially to evaluate progress in research objectives of the GVAP. GVIRF will continue to serve as a central forum for research related to Immunization Agenda 2030 (IA2030), the successor of the GVAP, and allow the vaccine and immunization research communities to gather and address research challenges, innovations, and opportunities leading toward the final strategic goal of IA2030: leave no one behind.
Main Areas of Focus
- Track progress and challenges related to priority vaccine research and development (R&D), including progress in achieving IA2030 SP7 R&D strategic objectives and goals
- Identify gaps, opportunities, and actions for the R&D community in the areas of vaccines and immunization
- Create opportunities for networking and collaboration among the vaccine R&D and immunization communities
- Expand capabilities of engagement with end users
- Enable innovation and development of new vaccines
- Accelerate development, licensing, and update of vaccinesF
- Improve program efficiencies and increase vaccine coverage